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Summary
Background: Several specialist clinic-based epidemiology studies suggested low pre-
valence in Hong Kong Special Administrative Region (HKSAR) of China. Population-
based epidemiological data for epilepsy is not available. We performed the first
population-based epidemiological survey of epilepsy in this locality.
Method: We conducted a territory-wide survey. We randomly selected 9547 house-
holds from fixed-line telephone directory. We successfully surveyed 17,783 persons of
5178 households by telephone interview. All positive respondents 685 (3.85%) were
invited for clinical validation. 127 subjects were validated by board-certified neurol-
ogists.
Results: Seizure disorders were confirmed in 28 subjects. The crude prevalence of
active epilepsy and seizure disorder were estimated to be 3.94/1000 (95% confidence
interval (CI): 2.10—6.74/1000) and 8.49/1000 (95% CI: 5.64—12.27/1000), respec-
tively.
Conclusions: The prevalence of epilepsy in HKSAR is more common than previously
thought. The data retrieved is useful for planning and allocation of health resources
for patients with seizure disorders.
# 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.* Corresponding author at: Hong Kong Epilepsy Society, c/o 901
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Administrative Region, China. Tel.: +852 2521 2565;
fax: +852 2521 6068.
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Epilepsy is a common neurological disease in the
developed world. It was estimated that 45—100
million people have active epilepsy worldwide.1
The reported point prevalence for active epilepsy. Published by Elsevier Ltd. All rights reserved.
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4 to 7 per 1000,2 with limited data available for
Chinese populations.3—5 In this locality, several
clinic-based studies were conducted with estimated
prevalence figures from 0.5 to 1.5 per 10006—9 which
are likely to be a gross under-estimation.10
Hong Kong Special Administrative Region (HKSAR)
is a metropolitan city with a population of over 6.7
million (97% ethnical Chinese). Despite its affluence
in economical terms (with gross national income per
capita ranked 15th in the World in 2002),11 popula-
tion-based health census data for seizure disorders
are not available.
A door-to-door approach is a standard commu-
nity-based epidemiological survey method.5,12,13
However, because of the existing socioeconomic
architecture and cultural reasons, it may be imprac-
tical in this locality. Alternative method, such as
telephone screening followed by clinical validation,
has been tried with success.14,15 Using a similarTable 1 Age and sex distribution of positive respondents
Questions Age group
0—14 15—24 25—34 35—44 45—54
Q1
+ve 26 50 34 47 55
% 0.95 1.54 1.39 1.64 1.89
Q2
+ve 16 21 14 25 30
% 0.58 0.65 0.57 0.87 1.03
Q3
+ve 10 24 15 14 26
% 0.36 0.74 0.61 0.49 0.90
Q4
+ve 9 22 9 10 16
% 0.33 0.68 0.37 0.35 0.55
Q5
+ve 44 50 52 69 69
% 1.60 1.54 2.12 2.40 2.38
Q6
+ve 72 89 50 22 5
% 2.62 2.74 2.04 0.77 0.17
Q7
+ve 5 15 10 6 2
% 0.18 0.46 0.41 0.21 0.07
Questions: sensitivity and specificity for seizure disorder — (1) have
consciousness or loss of consciousness? (Sensitivity: 54.8%, specificity
episodes of sudden involuntary jerky movement affecting limbs, face
96.0%); (3) have you or your family members experienced sudden
(Sensitivity: 13.3%, specificity: 97.4%); (4) have you or your family m
with surrounding and staring, not responding to others’ call? (Sen
members undergone electroencephalography examination? (Sensit
members experienced febrile convulsion before age of 5, i.e., c
specificity: 96.0%); (7) have you or your family members ever bee
(Sensitivity: 25.0%, specificity: 99.2%).approach, we conducted a population-based epide-
miological study for seizure disorders in Hong Kong.Methods and materials
A questionnaire with 7 screening questions was
designed specifically for the study. An English trans-
lated version is reproduced in Table 1. The ques-
tionnaire was validated with a cohort of 100
patients with seizure disorders and 100 normal
controls.
The actual study was conducted in two stages,
namely, a telephone screening phase followed by
clinical validation. In addition to the 7 screening
questions, demographic data (age, sex, education
level, marital status, occupation and location of
residence address) was also obtained at the time
of telephone interview (Fig. 1). The study was
approved by the ethics committee of InstitutionalSex
55—64 >= 65 Total Male Female Total
49 96 357 166 188 354
3.03 4.95 2.01 1.92 2.11 2.02
22 71 199 88 109 197
1.36 3.66 1.12 1.02 1.22 1.12
21 64 174 75 98 173
1.30 3.30 0.98 0.87 1.10 0.99
11 32 109 52 54 106
0.68 1.65 0.61 0.60 0.61 0.60
78 142 504 247 252 499
4.82 7.32 2.83 2.86 2.83 2.84
7 9 254 135 118 253
0.43 0.46 1.43 1.56 1.32 1.44
7 3 48 27 21 48
0.43 0.15 0.27 0.31 0.24 0.27
you or your family members suffered from transient lapses of
: 94.9%); (2) have you or your family members ever experienced
s or head regions in the day time? (Sensitivity: 19.4%, specificity:
drop attacks with tongue biting and/or urinary incontinence?
embers experienced lapse of consciousness with loss of contact
sitivity: 6.9%, specificity: 97.8%); (5) have you or your family
ivity: 37.5%, specificity: 93.7%); (6) have you or your family
onvulsion associated with febrile illness? (sensitivity: 48.6%,
n diagnosed to have epilepsy or seizure disorders by doctors?
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Figure 1 Flow chart of study.Review Board of the University of Hong Kong/Hos-
pital Authority Hong Kong West Cluster.
Phase I
Professional telephone interview service (Social
Science Research Centre of The University of Hong
Kong) conducted the telephone interview from July
to August 2003. Fixed-line household telephone
numbers were randomly selected from their com-
puter database. Adults of 15 years or older were
invited to response (and on behalf of other family
members if the respective family member was not
available). There was no age limit for individual
household members. Considering the averaged
household members in HKSAR (at 2001) were 3.23
per household, for practical purposes, the eldest 5
family members were surveyed if the household
held more than 5 members. Demographic data from
each respondent was obtained. Demographic data
would be compared with the general HKSAR popula-
tion data reported in the 2001 census.
Phase II
Positive respondents (who responded positive to
screening questions) were invited for clinical vali-
dation (September to October 2003). At the time of
clinical validation, all subjects were seen by board-
accredited neurologists to document the presence
of seizure disorder and its details (such as age ofonset, seizure semiology, possible aetiology, family
history, previous EEGs, neuroimaging results, anti-
epileptic drug prescriptions).
Epilepsy was defined as two or more clinically
evident afebrile unprovoked seizure. Active epi-
lepsy is defined as a person with epilepsy who
experienced at least one seizure in the previous 5
years, regardless of antiepileptic drug treatment.
Seizures were classified according to the criteria of
the International League Against Epilepsy (ILAE)16
and with concurring opinion from at least two neu-
rologists. EEG data is optional.
The clinical validation was performed by neurol-
ogists from four regional hospitals, namely, Queen
Mary Hospital (VW, JF, GCF), Prince ofWales Hospital
(AH), Queen Elizabeth Hospital (CL) and United
Christian Hospital (PK).
Sample size and statistical analysis
We aimed to sample 15,000 household members,
which would have a margin of error (sampling error)
within the range of +0.11% to +0.16% at the 95% level
of confidence, assuming that the prevalence of
epilepsy in the population was in the range of
0.5—1%. Characteristics between groups were com-
pared using t-test and Chi-square test where appro-
priate. All statistical tests were two-tailed at
a = 0.05. Prevalence rates were calculated in the
population studied with the assumption that
the number of confirmed cases followed a Poisson
460 G.C.Y. Fong et al.distribution. Statistical calculations were per-
formed using SPSS Version 11.5 for Windows soft-
ware (Chicago, IL).Results
Phase I
We randomly selected 9547 fixed-line telephone
numbers. They were approached and 5178 (54.2%)
households responded successfully. The total popu-
lation was estimated to be 17,783 persons. The
demographic data (age, sex, education level,
employment and areas of residence) of the respon-
dents were similar to those of the general popula-
tion as reported in the 2001 census of HKSAR17
(Table 2).
The questions were answered positively by 357
(2.0%) subjects for question 1 (episodes of loss of
consciousness), 199 (1.1%) subjects for question 2
( features suggestive of generalized tonic—clonic
convulsion), by 174 (1.0%) for question 3 (drop
attacks or urinary incontinence or tongue biting),
109 (0.6%) for question 4 ( features suggestive of
complex partial seizures), 254 (1.4%) for question 6
( febrile convulsion).
48 (0.3%) subjects were told to have epilepsy or
seizure disorders by their physicians (question 7);
and 504 (2.8%) subjects underwent EEG examination
in their lifetime (question 5).
Overall, 685 (3.85%, from 614 households) gave
positive responses. 232 households with positive
respondents agreed to be contacted for clinical
validation.
Phase II
Between September and October 2003, we con-
ducted the clinical validation. All positive respon-
dents agreed for clinical validation were contacted.
127 positive respondents (18.5%, 121 households
with 429 members) attended the clinical assess-
ment. Demographic data of the validated positive
respondents were similar to those of positive
respondents refused to be validated. Demographic
data of the families of the validated positive respon-
dents were similar to those families of studied
population (Table 2).
Clinical evaluation confirmed 28 patients with
seizure disorders (history of febrile convulsion: 15,
active epilepsy: 13). Among patients with active
epilepsy, 6 had generalized tonic—clonic seizure
and 6 had complex partial seizure with or without
secondary generalization. The seizure type of a
patient, with active epilepsy, could not be classified.Thirteen patients with active epilepsy were
found among the 127 validated positive respon-
dents. Hence, we estimated that 70 cases of active
epilepsy should be identified among the 685 positive
respondents screened. This gave us an estimated
overall prevalence for active epilepsy of 3.94/1000
(95% CI 2.10—6.74/1000).
For febrile convulsion, 15 cases were confirmed
from the 127 validated positive respondents. We
estimated that 80 subjects with history of febrile
convulsion should be found among the 685 positive
respondents. Hence, the estimated prevalence for
febrile convulsion is 4.55/1000 (95% CI 2.55—7.50/
1000).
Overall, the estimated prevalence for seizure
disorders is 8.49/1000 (95% CI 5.64—12.27/1000).
Based on the 2001 census in Hong Kong with a
total population of 6,708,389,17 it is estimated that
there are 26,447 people with active epilepsy, 30,504
people with history of febrile convulsion, and 56,949
people having seizure disorders in their lifetime in
Hong Kong.Discussion
Only a few epidemiologic surveys on epilepsy were
conducted in Chinese populations.3,5,18 Li et al.
reported a lifetime prevalence of epilepsy of 4.4
per 1000 in urban areas of China.3 In rural China, it
was estimated to be 7/1000 in a recent ‘‘demon-
stration project’’ of the ILAE/IBE/WHO Global Cam-
paign Against Epilepsy.5 On the other hand, locally,
three specialist-centre based surveys reported a
relatively low prevalence rate for epilepsy of
0.45—1.54 in 1000.6—8 The low estimated preva-
lence could be due to under-reporting secondary
to denial of illness, psychosocial stress and stigma-
tization associated with epilepsy.19—21 In addition,
centre-based epidemiological studies are prone to
under-estimate the true disease burden due to
selection bias.1,2 Hence, we conducted the first
population-based study to investigate the epide-
miology data for seizure disorder in our society.
The information obtained in this study is important
for Chinese populations living in a similar metropo-
litan city.
This study showed a prevalence of active epilepsy
of 3.94/1000. The figure was similar to other epi-
demiological studies conducted in industrialized
countries (Table 3). Our rate was intermediate com-
pared with the reported figures from United States
and Europe. It was lower among some other Asian
countries such as India and Japan.22—24 Compared
with figures worldwide, the prevalence rate of epi-
lepsy at Hong Kong was at the lower end of the
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Table 2 Demographic data of all respondents
Validated patients with Validated subjects All respondents (%) Total a
Seizure disorder Total (%)
Epilepsy Febrile convulsion
Age_GP
0—14 2 2 65 (15) 2754 (15) 2819
15—24 1 5 63 (15) 3249 (18) 3312
25—34 4 3 59 (14) 2450 (14) 2509
35—44 1 3 81 (19) 2870 (16) 2951
45—54 2 0 68 (16) 2903 (16) 2971
55—64 1 1 40 (9) 1618 (9) 1658
>65 2 1 53 (12) 1939 (11) 1992
Total 429 (100) 17783 (100) 18212
Sex
Male 9 8 222 (52) 8640 (49) 8862
Female 4 7 207 (48) 8908 (51) 9115
Total 429 (100) 17548 (100) 17977
Education
Uneducated/Kindergarten 1 1 35 (9) 1561 (9) 1596
Primary 4 3 103 (25) 3449 (21) 3552
F1—F3 2 4 79 (19) 2838 (17) 2917
F4—F5 1 5 91 (22) 4773 (29) 4864
F6—F7 0 2 22 (5) 1004 (6) 1026
University: non-Degree 1 1 22 (5) 545 (3) 567
University: Degree 2 1 57 (14) 2274 (14) 2331
Refuse to answer 0 0 0 (0) 123 (1) 123
Total 409 (100) 16567 (100) 16976
Marital
Single 9 10 183 (43) 7438 (43) 7621
Married 2 5 221 (52) 9036 (52) 9257
Widow 1 0 15 (3) 599 (3) 614
Divorced/separated 0 0 5 (1) 183 (1) 188
Total 424 (100) 17256 (100) 17680
Occupation
Executives 0 0 13 (3) 607 (4) 620
Professional 0 0 21 (5) 842 (5) 863
Professional assistant 2 2 16 (4) 587 (4) 603
Clerk 0 1 38 (9) 1582 (10) 1620
Machine operation 2 0 27 (7) 1530 (9) 1557
Service/sales 0 0 5 (1) 357 (2) 362
Art or related 1 0 13 (3) 613 (4) 626
Non-technical staff 1 0 23 (6) 893 (5) 916
Farm or unclassified 6 0 7 (2) 155 (1) 162
Other (student, housewife,
unemployed, retired, etc.)
0 13 249 (60) 9325 (56) 9574
Refused 0 0 0 (0) 161 (1) 161
Total 412 (100) 16652 (100) 17064
Region
Hong Kong 9 2 49 (16) 1769 (17) 1818
Kowloon 1 3 79 (25) 3333 (32) 3412
New Territory 2 6 173 (55) 5250 (50) 5423
Island 1 1 12 (4) 117 (1) 129
Total 13 15 313 (100) 10469 (100) 10782
a Missing variables exist in different subgroups.
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Table 3 Prevalence of epilepsy in selected countries
or regions
Year
reported
Country/city Prevalence
(/1000)
1960 Guam27 61.8
1961 Carlisle 28 5.7
1969 Poland29 8.9
1973 Norway30 3.5
1974 Alabama31 9.3
1978 Copiah County32 10.7
1983 China33 4.5
1985 Bombay22 4.9
1993 Iceland34 4.8
1994 Bolivia35 11.1
1995 Norway36 5.1
1997 Estonia37 5.3
1998 Madrid38 4.12
1999 Istanbul 39 8.0
2000 Jinshan of Shanghai,
China4
3.7 (rural);
2.45 (town)
2000 Izmir, Turkey40 5.6
2000 Saudi Arabia41 6.54
2000 Thailand42 7.2
2001 Sicilian43 3.3
2004 Hong Kong (present study) 3.94spectrum, similar to Madrid or Iceland. Comparing
to our neighbourhood cities, we are similar to rural
area of Jinshan region of Shanghai, but lower than
the rest of China or Thailand. The difference in
prevalence figures might be due to differences in
methodology for case ascertainment. In addition,
the result of surveys can be adversely affected by
the cultural differences towards patients with epi-
lepsy regarding the willingness of disclosing the
information to surveyors.21
Door-to-door survey is the gold standard for epi-
demiological study. However, in a metropolitan city
like Hong Kong, it is bound to face significant sam-
pling error, especially for disease with significant
social stigmata like seizure disorder.21 In Hong Kong,
it is possible that a household will refuse home visit
if there is a member with seizure disorder. It was
estimated that 19.3% of general population would
conceal their family member with epilepsy if they
were being asked.21 In addition, since the majority
of residential buildings in Hong Kong are skyscrapers
with security guards to scrutinize visitors at the
entrance of the building, interviewers might not
be able to enter the building. Sending a letter of
intent to arrange an interview may end up seeing a
skewed population who wished to be assessed. How-
ever, because of the associated social stigmata with
the disease, families with seizure disorder could be
reluctant to be interviewed during home visit. On
the contrary, it may be more psychosocially accep-
table over a telephone interview. As the coverage offixed telephone lines is extensive and approaches
100% of residential households,25 it provided a
golden opportunity to utilize the network. At the
month end of August 2003, when we performed the
phase I of the survey, there were 3,811,699 fixed
telephone lines installed, among which 2,121,536
were residential.25 Considering of the above men-
tion factors and with the extensiveness of fixed
telephone line coverage, we believe telephone sur-
vey and followed by clinical validation is probably
the only way of such study can be conducted in a
community of this nature. Furthermore, to ensure a
high quality data collection at the screening phase,
we employed professionally trained staffs with
extensive experience of conducting telephone sur-
veys in the local community. The percentage of
households completed the telephone screening
questionnaire, and the percentage of positive
respondents attended for clinical validation in the
present study were similar to those of a previous
survey on the prevalence of headache using a similar
protocol by the same group of staffs.15
The overall false positive rate of the screening
phase appeared to be high (78%). Most of the false
positive answers belong to questions 1, 2 and 4,
which were designed to detect subjects with lapses
of consciousness, involuntary jerking movement
resembling generalized tonic—clonic seizures, and
complex partial seizures, respectively. The high
false positive rate could be partly due to confusion
arisen from Cantonese, the spoken Chinese dialect
in Hong Kong. For instance, [Wan4]26 can refer to
‘‘dizziness, vertigo, lapse of consciousness, syn-
cope, or faint’’ (question 1) or [Cau1 gan1]26 can
refer to ‘‘seizure, muscle cramp, or twitching’’
(question 2). Thus subjects with muscle cramps,
vertigo and dizziness were responded positively
and were invited for clinical validation. In studies
conducted in China where Putunghua is the main
dialect,3—5 such semantic problems shall be less
significant as ‘‘seizure’’ and ‘‘lapse of conscious-
ness’’ can be expressed more precisely. In addition,
confusion between electroencephalography and
electrocardiography (question 5) could also be a
source of false-positive answers. Indeed, misunder-
standing of questions 1 and 5 was also the likely
reasons for the comparatively lower attendance
rate for validation in subjects who gave positive
answers to these 2 questions. Because of the low
sensitivity of these 2 questions, this low attendance
rate for validation was unlikely to have led to sig-
nificant under-estimation of the final prevalence
results.
Based on our data, the prevalence of epilepsy in
Hong Kong was estimated to be 3.94 per 1000. It was
much higher than the earlier figures obtained by
Epidemiological study of epilepsy in Hong Kong 463previous clinic-based studies. Our estimation was
closer to those reported in Mainland China and else-
where (Table 2). Because of the high degree of
stigmatization and negative attitude of the general
public toward patients with epilepsy in the
society,21 it is possible that some patients might
have refused to disclose their personal information
during the survey causing under-estimation of the
‘‘true’’ prevalence. In addition, only patients with
active epilepsy were validated clinically. It was
likely due to a bias of who agreed to be examined
among those positive respondent. For febrile con-
vulsion, the retrospective nature of the survey also
poses problems when assessing the prevalence of
febrile convulsion. Failure of recall of a childhood
event with no long-term consequence is common.
Given these limitations, we believe the measured
prevalence is the best estimation of the local figure
and approaching the ‘‘true’’ prevalence. While we
are waiting long for a door-to-door survey for
patients with seizure disorder in this locality, this
study can provide baseline data for health care
administrators, clinicians and patients, and has
implications for the allocation of resources and
training of medical manpower.Acknowledgments
We would like to express our thanks to the members
of the public who participated in the project.We are
indebted to Ms. Alsa Lin of United Christian Hospital
and Stella Hui of Queen Mary Hospital for adminis-
trative assistance in the clinical validation. We
thank Miss Evelyn Yu for assistance in statistical
analysis. This project was supported in part by an
unrestricted grant of Hong Kong Epilepsy Society.References
1. Hauser WA, Hesdorffer DC. Incidence and prevalence. In:
Hauser WA, Hesdorffer DC, editors. Epilepsy: frequency,
causes and consequences. New York: Demo; 1990. p. 1.
2. Sander JWAS, Shorvon SD. Epidemiology of the epilepsies. J
Neurol Neurosurg Psychiatry 1996;61:433—43.
3. Li SC, Schoenberg BS, Wang CC, Cheng X, Zhou S, Boli CL.
Epidemiology of epilepsy in urban areas of the People’s
Republic of China. Epilepsia 1985;26:391—4.
4. Huang M, Hong Z, Zeng J, Rong X, Sheng Y, Lu C. The
prevalence of epilepsy in rural Jinshan in Shanghai. Zhonghua
Liu Xing Bing Xue Za Zhi 2002;23:345—6.
5. Wang WZ, Wu JZ, Wang DS, Dai XY, Yang B, Wang TP, et al. The
prevalence and treatment gap in epilepsy in China. An ILAE/
IBE/WHO study. Neurology 2003;60:1544—5.
6. Fong GC, Mak W, Cheng TS, Chan KH, Fong JK, Ho SL. A
prevalence study of epilepsy in Hong Kong. Hong Kong Med J
2003;9:252—7.7. Kwong KL, Chak WK, Wong SN, So KT. Epidemiology of child-
hood epilepsy in a cohort of 309 Chinese children. Pediatr
Neurol 2001;24:276—82.
8. Ng KK, Ng PW, Tsang KL. Clinical characteristics of adult
epilepsy patients in the 1997 Hong Kong epilepsy registry.
Chin Med J 2001;114:84—7.
9. Wong V. A study of seizure and epilepsy in Chinese children–—
period prevalence and pattern: a study in Hong Kong. J Child
Neurol 2004;19:19—25.
10. Hui A, Kwan P. Prevalence of epilepsy in Hong Kong. Hong
Kong Med J 2004;10:70. [letter].
11. World Bank. World development indicators database, July
2003. www.worldbank.org/data/databytopic/GNIPC.pdf.
Accessed 3 February 2004.
12. Placencia M, Suarez J, Crespo F, Sander JWAS, Shorvon SD,
Ellison RH, et al. A large-scale study of epilepsy in Ecuador:
methodological aspects. Neuroepidemiology 1992;11:74—
84.
13. Radhakrishnan K, Pandian JD, Santhoshkumar T, Thomas SV,
Deetha TD, Sarma PS, et al. Prevalence, knowledge, atti-
tude, and practice of epilepsy in Kerala, South India. Epi-
lepsia 2000;41:1027—35.
14. Chang Y-C, Guo N-W, Huang C-C, Wang S-T, Tsai J-J. Neuro-
cognitive attention and behavior outcome of school-age
children with a history of febrile convulsions: a population
study. Epilepsia 2000;41:412—20.
15. Cheung RTF. Prevalence of migraine, tension-type headache,
and other headaches in Hong Kong. Headache 2000;40:473—
9.
16. Commission on Classification Terminology of the Interna-
tional League Against Epilepsy. Proposal for revised classifi-
cation of epilepsies and epileptic syndromes. Epilepsia
1989;30:389—99.
17. http://www.info.gov.hk/censtatd/eng/hkstat/fas/pop/
pop_vital_index.html. Last accessed April 24, 2004).
18. Kong FY. An analytic epidemiologic survey of epilepsy in the
Hui and Han nationality districts of Yinchuan. Chung Hau Shen
Ching Ching Shen Ko Tsa Chih 1989;22:111—3.
19. Lai CW, Huang XS, Lai YH, Zhang ZQ, Liu GJ, Yang MZ. Survey
of public awareness, understanding, and attitudes toward
epilepsy in Henan Province, China. Epilepsia 1990;31:182—7.
20. Chung MY, Chang YC, Lai YH, Lai CW. Survey of public
awareness, understanding, and attitudes toward epilepsy
in Taiwan. Epilepsia 1995;36:488—93.
21. Fong CY, Hung A. Public awareness, attitude, and under-
standing of epilepsy in Hong Kong Special Administrative
Region, China. Epilepsia 2002;43:311—6.
22. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoen-
berg BS. Prevalence of epilepsy in the Parsi community of
Bombay. Epilepsia 1988;29:111—5.
23. Hauser WA, Annergers JF, Kurland LT. Prevalence of epilepsy
in Rochester, Minnesota: 1940—1980. Epilepsia 1991;32:
429—45.
24. Tsuboi T. Prevalence and incidence of epilepsy in Tokyo.
Epilepsia 1988;29:103—10.
25. http://www.ofta.gov.hk/frameset/facts_index_eng.html.
Last accessed April 24, 2004.
26. http://www.arts.cuhk.edu.hk/Lexis/Canton/. Last accessed
April 24, 2004.
27. Lessel S, Torres JM, Kurland LT. Seizure disorders in a Gua-
manian Village. Arch Neurol 1962;7:53—60.
28. Brewis M, Poskanzer DC, Rolland C, Miller H. Neurologic
diseases in an England City. Acta Neurol Scand
1966;42(S24):9—89.
29. Zielinski JJ. Epidemiology and medical—social problems of
epilepsy in Warsaw. Warsaw: Psychoneurological Institute;
1974.
464 G.C.Y. Fong et al.30. De Graaf AS. Epidemiological aspects of epilepsy in Norway.
Epilepsia 1974;15:291—9.
31. Hollingsworth JS. Mental retardation, cerebral palsy and
epilepsy in Alabama: a sociological analysis. Tuscaloosa,
Alabama: University of Alabama Press; 1978.
32. Haerer AF, Anderson DW, Schoenberg BS. Prevalence and
clinical features of epilepsy in a biracial United States popu-
lation. Epilepsia 1986;27:66—75.
33. Li SC, Schoenberg BS, Wang CC, Cheng XM, Zhou SS, Bolis CL.
Epidemiology of epilepsy in urban areas of the People’s
Republic of China. Epilepsia 1985;26:391—4.
34. Olafsson E, Hauser WA. Prevalence of epilepsy in rural Ice-
land: a population-based study. Epilepsia 1999;40:1529—34.
35. Nicoletti A, Reggio A, Bartoloni A, Failla G, Sofia V, Bartalesi F,
et al. Prevalence of epilepsy in rural Bolivia: a door-to-door
survey. Neurology 1999;53:2064—9.
36. Waaler PE, Blom BH, Skeidsvoll H, Mykletun A. Prevalence,
classification, and severity of epilepsy in children in western
Norway. Epilepsia 2000;41:802—10.
37. Oun A, Haldre S, Magi M. Prevalence of adult epilepsy in
Estonia. Epilepsy Res 2003;52:233—42.38. Luengo A, Parra J, Colas J, Ramos F, Carreras T, Fernandez-
Pozos MJ, et al. Prevalence of epilepsy in northeast Madrid. J
Neuro 2001;248:762—7.
39. Onal AE, Tumerdem Y, Ozturk MK, Gurses C, Baykan B,
Gokyigit A, et al. Epilepsy prevalence in a rural area in
Istanbul. Seizure 2002;11:397—401.
40. Aydin A, Ergor A, Ergor G, Dirik E. The prevalence of epilepsy
amongst school children in Izmir, Turkey. Seizure 2002;11:
392—6.
41. Al Rajeh S, Awada A, Bademosi O, Ogunniyi A. The preva-
lence of epilepsy and other seizure disorders in an Arab
population: a community-based study. Seizure 2001;10:
410—4.
42. Asawavichienjinda T, Sitthi-Amorn C, Tanyanont W. Preva-
lence of epilepsy in rural Thailand: a population-based study.
J Med Assoc Thai 2002;85:1066—73.
43. RoccaWA, Savettieri G, Anderson DW, Meneghini F, Grigoletto
F, Morgante L, et al. Sicilian Neuro-Epidemiologic Study
(SNES) Group. Door-to-door prevalence survey of epilepsy
in three Sicilian municipalities. Neuroepidemiology
2001;20:237—41.
